Respinova
Herzliya
About Respinova
Respinova provides pulmonary treatment devices. It develops a novel non-invasive technology, PulseHaler, that treats the core of COPD pathophysiology. They serve COPD patients. Their Pulsehaler is a novel treatment that uses dynamic air pressure pulses to facilitate the opening of airways and the clearance of mucus.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $5.1M
- Last round: Series Unknown (Oct 2020)
- Website: respinova.com
- Phone: +972-58-687-8812
Industries & Categories
Medical Device
Social Profiles
Canonical: https://fsome.com/organization/respinova-83503 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.